Insmed, Inc. (INSM)
124.03
-1.74
(-1.38%)
USD |
NASDAQ |
Aug 24, 16:00
124.03
0.00 (0.00%)
After-Hours: 20:00
Insmed Total Return Level : 125.77 for Aug. 21, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 21, 2026 | 125.77 |
| August 20, 2026 | 125.08 |
| August 19, 2026 | 130.66 |
| August 18, 2026 | 128.46 |
| August 17, 2026 | 128.32 |
| August 14, 2026 | 123.74 |
| August 13, 2026 | 126.33 |
| August 12, 2026 | 132.28 |
| August 11, 2026 | 132.57 |
| August 10, 2026 | 134.75 |
| August 07, 2026 | 131.10 |
| August 06, 2026 | 132.55 |
| August 05, 2026 | 99.02 |
| August 04, 2026 | 98.75 |
| August 03, 2026 | 98.45 |
| July 31, 2026 | 98.60 |
| July 30, 2026 | 101.49 |
| July 29, 2026 | 103.12 |
| July 28, 2026 | 104.13 |
| July 27, 2026 | 104.73 |
| July 24, 2026 | 106.92 |
| July 23, 2026 | 107.41 |
| July 22, 2026 | 106.64 |
| July 21, 2026 | 108.62 |
| July 20, 2026 | 107.02 |
| Date | Value |
|---|---|
| July 17, 2026 | 108.32 |
| July 16, 2026 | 107.46 |
| July 15, 2026 | 109.81 |
| July 14, 2026 | 110.11 |
| July 13, 2026 | 109.14 |
| July 10, 2026 | 115.61 |
| July 09, 2026 | 118.26 |
| July 08, 2026 | 116.53 |
| July 07, 2026 | 112.84 |
| July 06, 2026 | 111.54 |
| July 02, 2026 | 111.60 |
| July 01, 2026 | 107.00 |
| June 30, 2026 | 106.62 |
| June 29, 2026 | 104.74 |
| June 26, 2026 | 103.38 |
| June 25, 2026 | 104.47 |
| June 24, 2026 | 103.46 |
| June 23, 2026 | 102.15 |
| June 22, 2026 | 98.60 |
| June 18, 2026 | 95.80 |
| June 17, 2026 | 98.45 |
| June 16, 2026 | 95.52 |
| June 15, 2026 | 97.46 |
| June 12, 2026 | 97.85 |
| June 11, 2026 | 96.72 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Alnylam Pharmaceuticals, Inc. | 236.22 |
| United Therapeutics Corp. | 513.12 |
| ACADIA Pharmaceuticals, Inc. | 29.50 |
| Biogen, Inc. | 216.78 |
| Gilead Sciences, Inc. | 212.96 |